Čes. stomatol. Prakt. zub. lék. (Czech Dental Journal) 2010; 110(2): 26-31

Dental Care in Patients with Myasthenia Gravis

J. Pi»ha
Neurologická klinika 1. LF UK a VFN, Praha
Centrum myasthenia gravis, Praha

Myasthenia gravis is an autoimmune disease in the neuromuscular transmission, causing muscular weakness and fatique especially in the facial and pharyngeal muscles. The stomatology care provided to these patients should consider specificities of this disease. Some patients are afflicted by from residual disorders of muscles in the oral cavity, and others suffer from side effects of drugs which inhibit autoimmune inflammation. Various drugs can even deteriorate symptoms of the disease. Anesthesiology should also acquire specific approaches. Stomatologists should be aware of all risks associated with taking care of these patients, but their approach to the patients should not be accompanied by useless worries.

Keywords: myasthenia gravis; stomatology care; oropharyngeal weakness; drug intolerance; anaesthesia

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pi»ha J. Dental Care in Patients with Myasthenia Gravis. Čes. stomatol. Prakt. zub. lék. 2010;110(2):26-31.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bahn, S. L.: Glucococrticoids in dentistry. J. Am. Dent. Assoc., roč. 105, 1982, č. 3, s. 476-481. Go to original source... Go to PubMed...
    2. Bassler, R.: Histopathology of different types of atrophy of the human tongue. Path. Res. Pract., roč. 182, 1987, č. 1, s. 87-89. Go to original source... Go to PubMed...
    3. Bottomley, W. K., Terezhalmy, G. T.: Mangement of patients with myasthenia gravis who require maxillary dentures. J. J. Prosthget. Dent., roč. 38, 1977, č. 6, s. 609-614. Go to original source... Go to PubMed...
    4. Burch, J., Waren-Gash, C., Ingham, V., Patel, M., Bennett, D., Chaudhuri, K. R.: Myasthenia gravis - a rare presentation with tongue atrophy and fasciculation. Age Ageing, roč. 35, 2006, č. 1, s. 87-88. Go to original source... Go to PubMed...
    5. Butler, R. T., Kalwarf, K. L., Kaldahl, W. B.: Drug-induced gingival hyperplasia: phenytoin, cyclosporine and nifedipine. J. Am. Dent. Assoc., roč. 114, 1987, č. 1, s. 56-60. Go to original source... Go to PubMed...
    6. Calcaterra, T. C., Stern, F., Herman, C. Jr., Mudler, D. G.: The otolarylgologist's role in myasthenia gravis. Trans. Am. Ac. Optal. Otolaryngol., roč. 72, 1972, č. 2, s. 308-312.
    7. Carpanter, R. J., Macdonald, T. J., Howard, F. M. Jr.: The otolaryngoligic presentation of myasthenia gravis. Laryngoscope, roč. 89, 1979, č. 6, s. 992-998. Go to original source... Go to PubMed...
    8. Colton-Hudson, A., Koopman, W. J., Moosa, T., Smith, D., Bach, D., Nicolle, M.: A prospective assessment of the characteristics of dysphagia in myasthenia gravis. Dysphagia, roč. 17, 2002, č. 2, s. 147-151. Go to original source...
    9. Davison, S. P., Macdonald, T. J., Wolfe, M. E.: Swollen tongue: a presentation of myasthenia gravis. Otolaryngol Head Neck Surg., roč. 116, 1997, č. 2, s. 224-226. Go to original source... Go to PubMed...
    10. Dhillon, R. S., Brookes, G. B.: Myasthenia gravis in otolaryngologiocal practice. Clin. Otolaryngol Allen. Sci., roč. 9, 1984, č. 1, s. 27-34. Go to original source... Go to PubMed...
    11. Dillon, F. X.: Anesthesia issues in the perioperative management of children with myasthenia gravis. J. Dent. Children, roč. 45, 1978, č. 2, s. 47-50.
    12. Farrugia, M. E., Rondon, M. D., Clover, L., Anslow, P., Newsom-Davis, J., Kennett, R., Hilton-Jones, D., Matthews, P. M., Vincent, A.: MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain, roč. 129, 2006, č. 6, s. 1481-1492. Go to original source...
    13. Howard, J. F. Jr.: Adverse drug interactions in disorders of neuromuscular transmission. J. Neurol. Orthop. Med. Surg., roč. 12, 1991, č. 3, s. 26-34.
    14. Kernstine, K. H.: Preoperative preparation of the patient with myasthenia gravis. Thorac Surg. Clin., roč. 15, 2005, č. 2, s. 287-296. Go to original source... Go to PubMed...
    15. Klein, K. J., Bromberg, M. B., Feldman, E. L., Simmons, Z.: Dysphagia in elderly men with myasthenia gravis. J. Neurol. Sci., roč. 138, 1996, č. 1-2, s. 49-52. Go to original source... Go to PubMed...
    16. Llabres, M., Molina-Martinez, F. J., Mirrales, F.: Dysphafia at sole manifestation of myasthenia gravis. J. Neurol. Neurosurg. Psychiatry, roč. 79, 2005, č. 9, s. 1297-1300. Go to original source... Go to PubMed...
    17. Mason, D. K.: Oral aspects of myasthenia gravis. Dent. Practic., roč. 15, 1964, č. 2, s. 23-25.
    18. Miller, C. S., Little, J. W., Falace, D. A.: Supplemental corticosteroids for dental patients with adrenal insufficiency: reconsideration of the problem. J. Am. Dent. Assoc., roč. 132, 2001, č. 11, s. 1570-1579. Go to original source... Go to PubMed...
    19. Norman, E. L.: Myasthenia gravis: a nursing perspective. J. Neurosci. Nurs, roč. 18, 1986, č. 2, s. 74-80. Go to original source... Go to PubMed...
    20. Patron, L. L., Howarrd, Jr. J. F.: Myasthenia gravis: dental treatment considerations. Spec. Care Dent., roč. 17, 1997, č. 1, s. 25-32. Go to original source...
    21. Sanders, D. B., Howard, Jr. J. F., Johns, T. R., Campa, J. F.: High-dose daily prednisone in treatment of myasthenia gravis. In: Plasmapheresis and the Immunobiology of Myasthenia Gravis. Ed Dau PC. Boston, Houghton-Mifflin Publishers, 1979, s. 289-306.
    22. Sasakura, Y., Kumasaka, S., Takahashi, T., Shindo, J.:Myasthenia gravis associated with reduced masticatory function. Int. J. Oral. Maxillofac. Surg., roč. 29, 2000, č. 5, s. 381-383. Go to original source...
    23. Sabate, N. W., Seymour, G. J., Robinson, M. F.: Cyclosporin-A - inducend gingival enlargement. A case report. J. Periodontol, roč. 58, 1987, č. 7, s. 475-480. Go to original source... Go to PubMed...
    24. Scherer, K., Bedlack, R. S., Simel, D. L.: Does this patient have myasthenia gravis? JAMA, roč. 293, 2005, č. 15, s. 1906-1914. Go to original source... Go to PubMed...
    25. Schneider, P. E.: Dental management of a child with severe myasthenia gravis. Spec. Care Dent., roč. 3, 1993, č. 3, s. 266-270. Go to original source... Go to PubMed...
    26. Seymour, R. A., Thomason, J. M., Ellis, J. S.: The pathogenesis of drug-induced gingival overgrowth. J. Clin. Periodontol, roč. 23, 1996, č. 3, s. 165-175. Go to original source... Go to PubMed...
    27. Shaw, D. H., Cohen, D. M., Hoffman, M.: Dental treatment of patients with myasthenia gravis. J. Oral. Med., roč. 37, 1982, č. 4, s. 118-120.
    28. Spicer, G. H.: Dental clues to myasthenia gravis. Dental Survey, roč. 41, 1965, č.4, 56-58.
    29. Van der Blit, A., Weijnen, F. G., Bosman, F., van der Glas, H. W., Kuks, J. B. M.: Conroled study od EMG activity of jaw closers and openers masticationin patients with myasthenia gravis. Eur. J. Oral. Sci., roč. 109, 2001, č. 3, s. 60-164. Go to original source... Go to PubMed...
    30. Weijnen, F. G., van der Blit, A., Kuks, J. B., van der Glas, H. W., Oudenaarde, I., Bosman, F.: Masticatory performance in patients with myasthenia gravis. Arch. Oral. Biol, roč. 47, 2002, č. 5, s. 393-398. Go to original source... Go to PubMed...
    31. Weijnen, F. G., van der Blit, A., Sokle, J. H. J., Eassenberg, M. W. M., Oudenaarde, I.: Oral funkcions of patients with myasthenia gravis. Ann. NY Acad. Sci., roč. 41, 1998, č. 5, s. 773-776. Go to original source... Go to PubMed...
    32. Yarom, N., Bornea, E., Nissan, J., Gorsky, M.: Dental management of patients with myasthenia gravis: a literature rewiew. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., roč. 100, 2005, č. 2, s. 158-163. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content